Showing results (181-190 of 192) with videos related to
Sort By:
Pageof 20
Journal of Medical Virology|January 15, 2026
Effect of Glycated Hemoglobin Levels on Serum Mac-2 Binding Protein Glycosylation Isomer in the Diagnosis of Hepatitis C-Virus Related Hepatic FibrosisYu-Ping Chang, Yun-Chu Chen, Ji-Yuh Lee, et al.Rheumatology (Oxford, England)|August 12, 2025
Non-negligible risk of HBV reactivation among rheumatoid arthritis patients receiving JAK inhibitors: bridging the evidence gapTing-Yuan Lan, Tai-Ju Lee, Ting-Wei Chang, et al.Gut|January 20, 2026
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver diseaseYu-Ping Chang, Yun-Chu Chen, Pin-Nan Cheng, et al.Clinical Lymphoma, Myeloma & Leukemia|September 30, 2025
Molecular Milestones and Survival Outcomes of Ponatinib Treatment in Patients With Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Real-World AnalysisTai-Chung Tseng, Yu-Sung Chang, Xavier Cheng-Hong Tsai, et al.Alimentary Pharmacology & Therapeutics|January 15, 2022
Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis BHui-Han Hu, Wen-Juei Jeng, Mei-Hung Pan, et al.Clinical and Translational Gastroenterology|October 23, 2020
Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 PatientsYee Hui Yeo, Tai-Chung Tseng, Tetsuya Hosaka, et al.Ebiomedicine|July 24, 2023
Mechanical transmission of dengue virus by Aedes aegypti may influence disease transmission dynamics during outbreaksHsing-Han Li, Matthew P Su, Shih-Cheng Wu, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 2, 2024
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis CChun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 17, 2016
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsTung-Hung Su, Tsung-Hui Hu, Chi-Yi Chen, et al.Gastroenterology|October 21, 2018
Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysisYee Hui Yeo, Hsiu J Ho, Hwai-I Yang, et al.Pageof 20